Protection from rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1. Maximum influenza protection includes new strains Ohio/2003, Kentucky 2/95 and Newmarket 2/93.
DOSAGE & ADMINISTRATION:
For initial vaccination, give 2 ml IM, followed by a 2nd dose IM in 3-4 weeks. Administer a third dose 3-4 weeks later either IM or intranasally. Revaccinate annually prior to anticipated exposure. Call toll free 1-800-892-6978 or email us at email@example.com